Semaglutide as a promising treatment for hypothalamic obesity: a six-month case series on four females with craniopharyngioma
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Semaglutide as a promising treatment for hypothalamic obesity: a six-month case series on four females with craniopharyngioma ; day:1 ; month:8 ; year:2024 ; pages:1-8
Pituitary ; (1.8.2024), 1-8
- Urheber
-
Gjersdal, Erlend
Larsen, Liva Bundgaard
Ettrup, Kåre Schmidt
Vestergaard, Peter
Nielsen, Eigil Husted
Karmisholt, Jesper Scott
Müller, Hermann L.
Dal, Jakob
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s11102-024-01426-8
- URN
-
urn:nbn:de:101:1-2410250906220.024292372438
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:23 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Gjersdal, Erlend
- Larsen, Liva Bundgaard
- Ettrup, Kåre Schmidt
- Vestergaard, Peter
- Nielsen, Eigil Husted
- Karmisholt, Jesper Scott
- Müller, Hermann L.
- Dal, Jakob
- SpringerLink (Online service)
Ähnliche Objekte (12)
Hypothalamic glioma masquerading as craniopharyngioma
Diagnosis, Background, and Treatment of Hypothalamic Damage in Craniopharyngioma
Semaglutide treatment of hypothalamic obesity – a real-life data study
Integrated Microbiome and Metabolome Analysis Reveals Hypothalamic‐Comorbidities Related Signatures in Craniopharyngioma
Craniopharyngioma
Semaglutide
Childhood craniopharyngioma: greater hypothalamic involvement before surgery is associated with higher homeostasis model insulin resistance index
Craniopharyngioma : surgical treatment
Obesity and craniopharyngioma
Craniopharyngioma in Adults
Endoscopic Transsphenoidal Resection of Craniopharyngioma
Fenestrated optic nerve in craniopharyngioma
Hypothalamic glioma masquerading as craniopharyngioma
Diagnosis, Background, and Treatment of Hypothalamic Damage in Craniopharyngioma
Semaglutide treatment of hypothalamic obesity – a real-life data study
Integrated Microbiome and Metabolome Analysis Reveals Hypothalamic‐Comorbidities Related Signatures in Craniopharyngioma
Craniopharyngioma
Semaglutide
Childhood craniopharyngioma: greater hypothalamic involvement before surgery is associated with higher homeostasis model insulin resistance index
Craniopharyngioma : surgical treatment
Obesity and craniopharyngioma
Craniopharyngioma in Adults
Endoscopic Transsphenoidal Resection of Craniopharyngioma
Fenestrated optic nerve in craniopharyngioma
Hypothalamic glioma masquerading as craniopharyngioma
Diagnosis, Background, and Treatment of Hypothalamic Damage in Craniopharyngioma
Semaglutide treatment of hypothalamic obesity – a real-life data study
Integrated Microbiome and Metabolome Analysis Reveals Hypothalamic‐Comorbidities Related Signatures in Craniopharyngioma
Craniopharyngioma
Semaglutide
Childhood craniopharyngioma: greater hypothalamic involvement before surgery is associated with higher homeostasis model insulin resistance index
Craniopharyngioma : surgical treatment
Obesity and craniopharyngioma
Craniopharyngioma in Adults
Endoscopic Transsphenoidal Resection of Craniopharyngioma